Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Benicia, CA – FDA Inspections
Inspection records and compliance data for Linde Inc. in Benicia, California. 2 FDA inspections on record, last inspected November 20, 2013. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Benicia, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected October 26, 2011. Last inspected November 20, 2013.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 20, 2013 | NAI | Human Drugs · Drug Quality Assurance | 855887 |
| October 26, 2011 | NAI | Human Drugs · Drug Quality Assurance | 750134 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
3001452656
Address
331 E Channel Rd, Benicia, California 94510, United States
Country
United States
ID: fff1bab0-63b6-4a10-97cc-8a735c48f4d5